Author

D. W. Wang

Primary ORCID profile (0009-0000-2900-0651 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

D. W. WangiD1 paper · Suzhou University of Science and Technology

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

C. Chen· 1 shared C. Zhao· 1 shared I. Fleming· 1 shared J. Hu· 1 shared J. Wu· 1 shared M. Zhang· 1 shared X. Gao· 1 shared Z. Wen· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. Chen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Epoxyeicosatrienoic acids and sEH inhibition prevent cardiac dysfunction in CVB3-induced myocarditis by positively regulating type I interferon signaling

D. W. Wang, Z. Zhou, M. Zhang, C. Zhao, X. Gao, Z. Wen, J. Wu, C. Chen, J. Hu, I. Fleming

This study shows that EETs and sEH inhibitors prevent CVB3-induced myocarditis by enhancing type I interferon signaling and improving viral resistance.

bioRxiv · Feb 3, 2023 · PreprintImmunology